Blau H J, Schulz M
Arch Geschwulstforsch. 1980;50(2):178-81.
In the introduction we are giving an overview about the possibilities of treatment of acute leucemias in childhood with an adjuvant immunotherapeutic component. Our own ten-years-experiences from 25 a. 1.1. children with BCG-application are useful for testing this kind of adjuvant therapy under clinical conditions in future, too.
在引言部分,我们概述了采用辅助免疫治疗成分治疗儿童急性白血病的可能性。我们从25名于1月1日接种卡介苗的儿童身上获得的十年经验,对于今后在临床条件下测试这类辅助治疗也很有用。